Nordic Luveris Study

PHASE4CompletedINTERVENTIONAL
Enrollment

526

Participants

Timeline

Start Date

August 31, 2003

Study Completion Date

November 30, 2004

Conditions
InfertilityIn Vitro Fertilization
Interventions
DRUG

recombinant luteinizing hormone (Luveris)

75 iu/day form cycle day 6

DRUG

recombinant follicle stimulating hormone (Gonal-f)

rFSH 150 iu/day

Trial Locations (1)

2100

Anders Nyboe Andersen, Copenhagen

All Listed Sponsors
collaborator

Regionshospitalet Viborg, Skive

OTHER

collaborator

Karolinska University Hospital

OTHER

collaborator

Helse Fonna

OTHER

collaborator

Turku Hospital

UNKNOWN

collaborator

Odense University Hospital

OTHER

collaborator

Herlev Hospital

OTHER

collaborator

Holbaek Sygehus

OTHER

collaborator

Hvidovre University Hospital

OTHER

lead

Rigshospitalet, Denmark

OTHER

NCT00553293 - Nordic Luveris Study | Biotech Hunter | Biotech Hunter